摘要
目的探究彩色多普勒超声诊断亚急性甲状腺炎的效果。方法方便选取2017年1月—2019年10月该院收取的亚急性甲状腺炎患者30例为实验组,同时选取30名健康体检者为对照组,其均接受彩色多普勒超声检查,对其检查的结果进行分析。结果实验组甲状腺长度(4.60±0.69)cm与对照组甲状腺长度(4.47±1.08)cm相比,差异无统计学意义(t=0.556,P=0.581)。实验组亚急性甲状腺炎患者的甲状腺宽度(1.88±0.20)cm、厚度(1.81±0.63)cm均高于对照组的甲状腺宽度(1.45±0.41)cm、厚度(1.22±0.30)cm,差异有统计学意义(t=5.163、4.631,P<0.05);实验组最高血流速度(47.80±4.23)cm/s高于对照组最高血流速度(24.32±2.87)cm/s,差异有统计学意义(t=25.159,P=0.001)。实验组甲状腺血流阻力指数(0.58±0.13)与对照组甲状腺血流阻力指数(0.61±0.08)相比,差异无统计学意义(t=1.076,P=0.286)。结论亚急性甲状腺炎患者接受彩色多普勒超声检查,能够对其疾病的确诊以及治疗方案的选择,提供参考依据。
Objective To investigate the effect of color Doppler ultrasound in the diagnosis of subacute thyroiditis.Methods Thirty patients with subacute thyroiditis in the hospital from January 2017 to October 2019 were convenient selected as the experimental group,and 30 healthy subjects were selected as the control group.All of them received color Doppler ultrasonography,and the results were analyzed.Results Compared with the control group(4.47±1.08)cm,the thyroid length(4.60±0.69)cm in the experimental group was not statistically significant(t=0.556,P=0.581).The thyroid width(1.88±0.20)cm and thickness(1.81±0.63)cm of the patients with subacute thyroiditis in the experimental group were higher than the thyroid width(1.45±0.41)cm and thickness(1.22±0.30)cm in the control group,the difference was statistically significant(t=5.163,4.631,P<0.05).The t values were respectively of the highest blood flow velocity(47.80±4.23)cm/s in the experimental group was higher than the maximum blood flow velocity(24.32±2.87)cm/s in the control group,and the differences were statistically significant(t=25.159,P=0.001).The thyroid blood flow resistance index(0.58±0.13)in the experimental group was not statistically significant compared with the thyroid blood flow resistance index(0.61±0.08)in the control group(t=1.076,P=0.286).Conclusion Color Doppler ultrasonography in patients with subacute thyroiditis can provide a reference for the diagnosis of the disease and the choice of treatment options.
作者
陈菲
CHEN Fei(Department of Imaging,Hospital of University of International Business and Economics,Beijing,100029 China)
出处
《中外医疗》
2020年第14期188-190,共3页
China & Foreign Medical Treatment